Comments
Alembic Pharmaceuticals has received approval from the US health regulator for Temazepam capsules which is used for the treatment of insomnia.
The company has got approval from the US Food and Drug Administration (USFDA) to market the drug in the strength of 7.5mg, 15mg, 22.5mg and 40mg, Alembic Pharmaceuticals said in a BSE filing today.
The approved abbreviated new drug application (ANDA) is the therapeutic equivalent to the reference listed drug product Restoril capsules. Quoting IQVIA sales data, the company said Temazepam capsules 7.5mg, 15mg, 22.5mg and 40mg had an estimated market size of $48 million for the 12 months ended December 2017.
Alembic Pharma shares were trading at Rs 567 apiece, up 1.33 per cent, on the BSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.